Cabaletta Bio, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Cabaletta Bio, Inc. on June 9, 2025, regarding events occurring at the Company's Annual Meeting of Stockholders held on the same date. The Company is incorporated in Delaware and its common stock trades on The Nasdaq Global Select Market under the symbol "CABA".
Key Financial Metrics
This filing is a corporate governance report and does not contain financial performance data. The filing text does not provide values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes and Corporate Actions
- Authorized Share Increase: Stockholders approved an amendment to the Third Amended and Restated Certificate of Incorporation, increasing the number of authorized shares of common stock from 150,000,000 to 300,000,000. The Certificate of Amendment was filed with the Delaware Secretary of State and became effective immediately.
- Director Elections: Stockholders elected Steven Nichtberger, M.D., and Mark Simon, MBA, as Class III directors for three-year terms expiring in 2028.
- Outstanding Shares: As of the record date (May 12, 2025), there were 50,743,101 outstanding shares of voting common stock.
Guidance, Outlook, and Voting Results
The filing details the results of six proposals submitted to stockholders:
- Proposal 1 (Directors): Steven Nichtberger, M.D., received 25,271,870 votes "For" and was elected. Mark Simon, MBA, received 13,482,164 votes "For" and was elected.
- Proposal 2 (Auditor): The appointment of Ernst & Young LLP as independent registered public accounting firm for fiscal year 2025 was ratified with 34,369,582 votes "For".
- Proposal 3 (Share Increase): The amendment to increase authorized shares was approved with 32,584,702 votes "For".
- Proposal 4 (Say-on-Pay): Executive compensation was approved on a non-binding advisory basis with 13,973,541 votes "For".
- Proposal 5 (Frequency of Say-on-Pay): Stockholders voted to hold future advisory votes on executive compensation annually (20,567,263 votes for 1 year).
- Proposal 6 (Adjournment): A proposal to adjourn the meeting if necessary was approved, though it was deemed not necessary as a quorum was present and Proposal 3 was approved.
Investor Verification Checklist
- Verify the effective date of the Certificate of Amendment with the Delaware Secretary of State.
- Review the full text of the Certificate of Amendment (Exhibit 3.1) for any additional terms regarding the share increase.
- Confirm the new total authorized share count of 300,000,000 in subsequent filings.
- Check the definitive proxy statement (Schedule 14A filed May 13, 2025) for detailed background on the director nominees and executive compensation.